immuno – English Translation – Keybot Dictionary

  10 Hits www.trans.civil.nagoya-u.ac.jp  

Show textShow cached sourceOpen source URL	La Fondation Charles-Bruneau signe le plus grand engagement de l’histoire du CHU Sainte-Justine pour la recherche en immuno-hémato-oncologie
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine charlesbruneau.qc.ca as primary domain	The Charles-Bruneau Foundation makes the largest donation in the CHU Sainte-Justine’s history to support immuno-hemato-oncology research

  www.genomecanada.ca  

Show textShow cached sourceOpen source URL

La nouvelle technologie conçue par Christoph Borchers, Ph. D., appelée immuno-MALDI (iMALDI), utilise les anticorps et la spectrométrie de masse pour surveiller les formes multiples de la protéine Akt au moyen d’une seule analyse.

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine genomecanada.ca as primary domain

AZD5363 is an anti-cancer drug in clinical development by AstraZeneca, which has been shown to stop tumour cell growth by inhibiting a protein called Akt. AstraZeneca and the clinical community want to be able to  understand more accurately which patients are likely to respond best to this drug and is conducting exploratory research on tumour tissue as well as blood to address this challenge.  New technology developed by Dr. Christoph Borchers, called immunoMALDI (iMALDI), uses antibodies and mass spectrometry to monitor for multiple forms of the Akt protein in a single assay. The clinical trials ongoing with AZD5363 provide the opportunity to validate iMALDI and proteomics in samples from patients with mutations in the PI3-kinase/Akt pathway and to test the concordance of iMALDI with other types of mutation testing for molecular signatures.

  2 Hits www.wma.net  

Show textShow cached sourceOpen source URL

L'augmentation des populations à haut risque ayant fréquemment besoin d'une antibiothérapie, notamment les sujets immuno-compromis, les personnes soumises à des interventions invasives, les personnes porteuses de dispositifs médicaux implantés et les patients souffrant d'affections débilitantes chroniques, a amplifié le problème.

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine wma.net as primary domain

The global increase in resistance to antimicrobial drugs, including the emergence of bacterial strains resistant to all available antibacterial agents, has created a multi-faceted public health problem of crisis proportions with significant economic and human implications. The development of resistant microorganisms is a problem whenever antimicrobial agents are used. The increase in high-risk populations who frequently require antimicrobial therapy, including immunocompromised patients, those undergoing invasive medical interventions, those with implanted medical devices and patients with chronic debilitating diseases, has amplified the problem. The fact that certain infectious diseases have been linked to the development of chronic disease and cancer adds another dimension to the problem.

  2 Hits www.cadth.ca  

Show textShow cached sourceOpen source URL

Le test Stratify JCV (Biogen Idec) est une analyse immuno-enzymatique (ELISA) en deux étapes qui, à partir de pseudo-particules virales, décèle les anticorps anti-JCV dans le sérum des patients atteints de SEP.

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine cadth.ca as primary domain

Screening for JCV by detecting its DNA in blood and urine samples does not appear to be sensitive enough and does not correlate well with PML risk. Another diagnostic approach involves detecting antibodies to JCV in the serum of patients. The Stratify JCV test (Biogen Idec) is a two-step, virus-like, particle-based, enzyme-linked immunosorbent assay (ELISA) designed to detect serum anti-JCV antibodies in MS patients. Quantitative anti-JCV antibody assays have also been developed.

  www.innovation.public.lu  

Show textShow cached sourceOpen source URL	Développement de stratégies de vaccination : l’expérience acquise avec le développement de stratégies vaccinales contre la rougeole a continué d’être appliquée afin d’explorer les stratégies immuno-prophylactiques contre les carcinogènes.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine innovation.public.lu as primary domain	Development of vaccination strategies: The experience acquired with the development of measles vaccine strategies has been further applied to explore immune-prophylactic strategies against carcinogens; the approach is based on innovative conjugate vaccines.

  5 Hits www.agr.ca  

Show textShow cached sourceOpen source URL	Reuter, T.R., Gilroyed, B.H., Alexander, T.W., Balachandran, A., Czub, S., et McAllister, T.A. (2009). « Prion protein detection via direct immuno-quantitative real-time PCR. », Journal of Microbiological Methods, 78(3), p.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine agr.ca as primary domain	Reuter, T.R., Gilroyed, B.H., Alexander, T.W., Balachandran, A., Czub, S., and McAllister, T.A. (2009). "Prion protein detection via direct immuno-quantitative real-time PCR.", Journal of Microbiological Methods, 78(3), pp. 307-311. doi : 10.1016/j.mimet.2009.07.001

  72 Hits hc-sc.gc.ca  

Show textShow cached sourceOpen source URL

Instruments faisant appel à des micro-organismes ou à leurs constituants (gènes, protéines, enzymes) afin de transformer ou d'obtenir un produit qui sera utilisé dans le cadre du dosage immuno-enzymatique, notamment par la technique ELISA, en vue de dépister des maladies infectieuses (hépatite B, hépatite C, infection par le VIH, fièvre du Nil occidental, ITS) ou de détecter des marqueurs tumoraux;

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine hc-sc.gc.ca as primary domain

Devices that use microorganisms or their elements (genes, proteins, enzymes) to transform or make a product and used in Enzyme-Linked Immuno Assays (EIA) such as ELISA, for the detection of infections (Hepatitis B, Hepatitis C, HIV, West Nile Virus, STDs) or tumour markers;

  72 Hits www.hc-sc.gc.ca  

Show textShow cached sourceOpen source URL

Instruments faisant appel à des micro-organismes ou à leurs constituants (gènes, protéines, enzymes) afin de transformer ou d'obtenir un produit qui sera utilisé dans le cadre du dosage immuno-enzymatique, notamment par la technique ELISA, en vue de dépister des maladies infectieuses (hépatite B, hépatite C, infection par le VIH, fièvre du Nil occidental, ITS) ou de détecter des marqueurs tumoraux;

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine hc-sc.gc.ca as primary domain

Devices that use microorganisms or their elements (genes, proteins, enzymes) to transform or make a product and used in Enzyme-Linked Immuno Assays (EIA) such as ELISA, for the detection of infections (Hepatitis B, Hepatitis C, HIV, West Nile Virus, STDs) or tumour markers;

  2 Hits www5.agr.gc.ca  

Show textShow cached sourceOpen source URL	Reuter, T.R., Gilroyed, B.H., Alexander, T.W., Balachandran, A., Czub, S., et McAllister, T.A. (2009). « Prion protein detection via direct immuno-quantitative real-time PCR. », Journal of Microbiological Methods, 78(3), p.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine www5.agr.gc.ca as primary domain	Reuter, T.R., Gilroyed, B.H., Alexander, T.W., Balachandran, A., Czub, S., and McAllister, T.A. (2009). "Prion protein detection via direct immuno-quantitative real-time PCR.", Journal of Microbiological Methods, 78(3), pp. 307-311. doi : 10.1016/j.mimet.2009.07.001

  2 Hits www.rce-nce.gc.ca  

Show textShow cached sourceOpen source URL	Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics (disponible en anglais seulement)
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine rce-nce.gc.ca as primary domain	Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics

  www.gimv.com  

Show textShow cached sourceOpen source URL	http://www.gimv.com/fr/medias/communiques-de-presse/gimv-investit-dans-imcheck-therapeutics-start-up-specialisee-en-immuno-oncologie
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine gimv.com as primary domain	http://www.gimv.com/en/media-and-news/press-releases/gimv-invests-in-emerging-immuno-oncology-company-imcheck-therapeutics

  2 Hits eshop.sa.zain.com  

Show textShow cached sourceOpen source URL	Immuno Holding S.A. de C.V., une société de portefeuille de Nexxus Capital, dans son acquisition et sa privatisation d'Immunotec Inc., pour la somme de 34 millions de dollars canadiens.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine stikeman.com as primary domain	Immuno Holding S.A. de C.V., a holding company of Nexxus Capital, in its C$34M acquisition and privatization of Immunotec Inc.

  evazdroj.pl  

Show textShow cached sourceOpen source URL	Potentiel de marché d’un nouveau traitement en immuno-oncologie dans plusieurs pays du Moyen-Orient
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine alcimed.com as primary domain	Market potential of a new immuno-oncology treatment in several countries in the Middle East

  www.uccm.md  

Show textShow cached sourceOpen source URL	Immuno-hématologie et sérologie non infectieuse
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine labo.itg.be as primary domain	Immuno-hematology and non-infectious serology

  113 Hits www.bmscanada.ca  

Show textShow cached sourceOpen source URL	L'Ontario est la toute dernière province à rembourser le traitement immuno-oncologique OPDIVOMD (nivolumab)
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine bmscanada.ca as primary domain	Ontario Latest Province to Cover Cost of Immuno-Oncology Treatment OPDIVO® (nivolumab)

  www.mangalica.com  

Show textShow cached sourceOpen source URL

La recherche de nouvelles molécules aux propriétés immuno-régulatrices et anti-tumorales chez les coraux est la principale activité de Coral Biome. Nos travaux de recherches en partenariat avec plusieurs grands laboratoires européens de cancérologie ont permis de mettre en évidence plusieurs composés bioactifs d’intérêt pour la lutte contre le cancer.

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine coralbiome.com as primary domain

The discovery of new molecules with immunoregulatory and antitumoral properties in corals is the main activity of Coral Biome. Our research in partnership with several major European laboratories of cancerology has helped to highlight several bioactive compounds of interest for fighting cancer. One biocompound with powerful anti-tumor properties is currently in development at Coral Biome and we hopefully soon realize the first clinical trials on the effects of this molecule.

  www.tod.org.il  

Show textShow cached sourceOpen source URL

Complémentaires des solutions thérapeutiques actuelles et futures (chimiothérapie, chirurgie, radiothérapie, anti-viraux, inhibiteurs de points de contrôle immunitaire), et utilisées le plus souvent en combinaison avec celles-ci, ces approches innovantes devraient permettre de répondre à de nombreux besoins médicaux aujourd’hui insatisfaits. Discipline en pleine évolution, l’immuno-oncologie s’impose progressivement comme le futur socle des traitements du cancer.

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine institut-merieux.com as primary domain

These innovative approaches are appropriate candidates for combinations with existing and future therapeutic solutions (chemotherapy, surgery, radiotherapy, antiviral therapy, immune checkpoint inhibitors), and should meet a number of unmet medical needs. Immuno-oncology is evolving fast and is progressively becoming a pillar of future cancer treatments.

  2 Hits www-ibmc.u-strasbg.fr  

Show textShow cached sourceOpen source URL	L’interactome se définit comme toutes les interactions possibles entre les molécules biologiques d’une cellule. Il peut être étudié par la technique des doubles hybrides, par immuno-coprécipitation et par l’étude physico-chimique de la liaison entre deux ou trois molécules.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine www-ibmc.u-strasbg.fr as primary domain	The interactoma encompasses all possible interactions between biological molecules in a cell. It can be studied by the two-hybrid technique, by immuno-coprecipitation and by the physico-chemical studies of the binding between two or three molecules. The latter possibility is used in the laboratory by means of surface plasmon resonance measurements.

  12 Hits www.kunstverein-muenchen.de  

Show textShow cached sourceOpen source URL	La Société a démarré en 2016 un nouveau programme de recherche en Immuno-Oncologie, avec son produit leader NBTXR3, qui pourrait potentiellement apporter une nouvelle dimension à l’immunothérapie en oncologie.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine nanobiotix.com as primary domain	The Company started in 2016 a new preclinical research program in Immuno-oncology with its lead product NBTXR3, which could have the potential to bring a new dimension to cancer immunotherapies.

  3 Hits www.christmas.portobay.com  

Show textShow cached sourceOpen source URL	Immuno-pharmacologie
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine mimabs.org as primary domain	Immuno-pharmacology

  4 Hits lms.vodeclic.com  

Show textShow cached sourceOpen source URL	Aujourd’hui, Marseille immunopôle, ses experts, ses plateformes, offrent un environnement scientifique pluridisciplinaire d’excellence pour ces recherches en immuno-oncologie thoracique.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine marseille-immunopole.org as primary domain	Today, Marseille Immunopôle and their experts and platforms provide an outstanding multidisciplinary scientific environment for thoracic immuno-oncology research.

  dfo-mpo.gc.ca  

Show textShow cached sourceOpen source URL	évaluation des besoins en ressources et de l'efficacité de l'immuno contraception pour régir les populations de phoques;
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine dfo-mpo.gc.ca as primary domain	evaluation of resource requirements and efficacy of immuno-contraception to control seal populations,

  106 Hits www.nml-lnm.gc.ca  

Show textShow cached sourceOpen source URL	Épreuve immuno-enzymatique (EIA)
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine nml-lnm.gc.ca as primary domain	Enzyme Immunoassay (EIA)

  2 Hits ossianvinos.com  

Show textShow cached sourceOpen source URL	Agro-Bio et l'immuno-technologie
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine agro-bio.com as primary domain	Agro-Bio and immuno-technology

  www.dfo-mpo.gc.ca  

Show textShow cached sourceOpen source URL	évaluation des besoins en ressources et de l'efficacité de l'immuno contraception pour régir les populations de phoques;
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine dfo-mpo.gc.ca as primary domain	evaluation of resource requirements and efficacy of immuno-contraception to control seal populations,

  4 Hits winzavod.ru  

Show textShow cached sourceOpen source URL	Groupe de travail Immuno Oncologie
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine sakk.ch as primary domain	Working Group Immuno Oncology

  eu.tamrieltradecentre.com  

Show textShow cached sourceOpen source URL	Régimes alimentaires spéciaux immuno-modulants et anti-âge.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine villaparadiso.com as primary domain	Special immunomodulating and anti-aging diets.

  102 Hits artogalleria.com  

Show textShow cached sourceOpen source URL	Immuno-oncologie
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine celyad.com as primary domain	Immuno-oncology

  cfs.nrcan.gc.ca  

Show textShow cached sourceOpen source URL

Nous l'avons conjugué à une protéine porteuse, l'hémocyanine de patelle. Nous avons ensuite immunisé des lapins contre le conjugué et nous avons purifié l'anticorps anti-peptidique par chromatographie d'immuno-affinité.

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine scf.rncan.gc.ca as primary domain

A 19-kDa protein (named Pin l I) of sugar pine was detected in increasing amounts in the fall. This protein was separated by SDS-PAGE and also by two-dimensional gel electrophoresis. Pin l I was composed of two acidic isoforms. This protein was subjected to N-terminal amino acid sequence analysis. The two isoforms had an identical N-terminal amino acid sequence. The N-terminal peptide was synthesized and purified, and the purity of the synthetic peptide was greater than 95%. The peptide was conjugated to a carrier protein, Kehole limphet hemocyanin (KLH). Rabbits were immunized with peptide-KLH and the anti-peptide antibody was purified from the crude antisera by immuno-affinity chromatography. The antibody was shown to bind specifically to Pin l I. This anti-Pin l I antibody was used in a Western immunoblot to detect the homologues of Pin l I in two other five-needled white pines: western (named Pin m III) and eastern white pine. The antibody was also used to monitor the seasonal variation of Pin m III in western white pine needles. Pin m III was shown to be associated with overwintering of western white pine seedlings. A significant correlation was observed between the frost hardiness of western white pine foliage and the content of Pin m III.

  2 Hits www.epo.org  

Show textShow cached sourceOpen source URL

Dans l'affaire T 485/99, la publication antérieure (1) de l'état de la technique avait déjà divulgué l'utilisation pour l'immuno-stimulation de la composition à la base de la revendication 1 du brevet en cause.

Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine epo.org as primary domain

In T 485/99 prior art document (1) had already disclosed the use for immunostimulation of the composition underlying claim 1 of the patent in suit. The only new feature of claim 1 was the fact that the intake of the immunostimulatory diet was pre-operative. In the opinion of the board it needed to be investigated whether the pre-operative therapy as defined in the claim could be distinguished from the therapy disclosed in document (1) by a different medical (physiological) effect due to this pre-operative administration and thus whether or not it related to a functional feature leading to the therapeutic indication within the meaning of G 5/83 (OJ 1985, 64). If it did not, the use defined in such a way might restrict the medical practitioner’s freedom when treating his patients (see T 56/97). Pre- or post-operative administration of the diet would then constitute methods for treatment of the human body and could thus not be regarded as patentable inventions under Art. 52(4) EPC 1973. The appellant had argued that the group of patients treated with the pre-operative diet could be distinguished from those treated with the post-operative diet. In the board’s opinion, the question raised was whether the physiological status of the patients caused by the pre-operative diet was different. The board concluded that this could not be established at present.